United States Patent and Trademark Office banner graphic

Coming February 24: Biopharma patents in China: Litigation, licensing, and patent linkage webinar

United States Patent and Trademark Office sent this bulletin at 02/16/2022 11:06 AM EST

Having trouble viewing this email? View it as a Web page.

USPTO Alert

Coming February 24: "Biopharma patents in China: Litigation, licensing, and patent linkage webinar"

Register to attend the United States Patent and Trademark Office's (USPTO) free, 90-minute webinar to learn about the latest developments in China affecting biopharmaceutical patents. The program will feature senior USPTO attorneys and seasoned practitioners with extensive China intellectual property (IP) experience. The speakers will explore the challenges and opportunities facing U.S. companies as they obtain, enforce, and license their biopharmaceutical IP rights in China.

The program will take place Thursday, February 24, from 9:30-11 a.m. ET. For more information, visit the event page on the USPTO website.

Stay connected with the USPTO by subscribing to regular email updates.

Visit our subscription center at www.uspto.gov/subscribe to update or change your email preferences.

This email was sent from an unmonitored mailbox. To contact us, please visit our website www.uspto.gov/about/contacts. To ensure that you continue to receive our news and notices, please modify your email filters to allow mail from subscriptioncenter@subscriptions.uspto.gov.